Promising drug doubled positive effect in hormone-receptor positive breast cancer, study finds

In a groundbreaking study that offers new hope for women with advanced breast cancer, researchers have published final clinical trial results that showed the amount of time patients were on treatment without their cancer worsening (called progression-free survival) was effectively doubled in women with advanced breast cancer who took the experimental drug palbociclib.

Read the whole article on Science Daily

More from Science Daily